Uptrend Under Pressure 93
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 93/100 · 7 distribution days (SPY) Sep 11 Full briefing →
View
Simple research view

ILMN · Illumina, Inc.

$201.27 -1.82% Sep 10 close
Detected setup Trend Only · Setup Score 81/100

Stand aside — setup invalidated

Setup score 81, but distribution days reach 5 or more — stand aside until the condition resets.

Ask about ILMN

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$ILMN

Illumina, Inc.

Illumina, Inc. is a large-cap Medical Specialties company in the Health Technology sector with a market cap of $30B.

Health Technology Medical Specialties stock Stage 2 · Advancing Base 2
$201.27 latest close
Join to Watchlist $ILMN Share card
Verdict · setup score 81/100 · data Sep 10 close · 1 session old

Stand aside — setup invalidated

Setup score 81, but distribution days reach 5 or more — stand aside until the condition resets.

Review six verdicts Inspect chart
Earnings

Normal technical setup

No sourced report date Event risk is not modelled for this symbol

Deterministic evidence

ILMN-1.82%
Sector proxy · XLV-0.55%
Broad market · SPY-0.60%
Same completed session window ending 2026-09-10. ILMN was -1.27 points vs XLV. -1.22 points vs SPY.

Session internals Weak

Rule: closed flat-to-down and in the bottom third of the range. Judged on internals, not on the size of the move.

Vs prior close-1.82% From the open-1.19% Range position13% GapNo gap
QQQ confirmationConfirming (-1.06%) SMH confirmationConfirming (-2.44%)
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $201.27 -1.8% Sep 10 close
52W High $231.81 13.2% below high
Wks Since High 1w
Base Depth 11.6% 13.5% today
RS Rank 89 percentile of scan
SMA 50 $199.85
Avg Vol 1,891,289
Rel Vol (Sep 10) 0.68×
More stats
52W Low $88.00
Tight Wks 0
Base B2
SMA 200 $153.15
RS Line vs High -10.1%
RS Line Slope +7.2% ▲
Group Rank #25/58
ADR% 4.1%
ATR(14) $8.91 (4.4%)
Vol Pace (live) N/A
U/D Vol 1.80
A/D Days 20A / 7D
A/D Rating A+
VDU Bars 0/10 d
Position in 52-week range 79thpercentile of the 52-week range
$88.00low
$231.81high

ILMN Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for ILMN.

Create Free Account

Technical Analysis Report Card

$ILMN · $201.27 · as of 2026-09-10 · multi-factor read
80
/ 100
Technicals 80/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▲ Uptrend
Monthly ▬ Sideways / consolidating

Moving Averages

50-day$199.85 ↑
100-day$175.32 ↑
200-day$153.15 ↑
Bullish (50 > 200)

RSI (14)

Reading45.6 · Neutral

Neutral — momentum is balanced between buyers and sellers.

MACD (12/26/9)

StateWeakening
Histogram-2.275

Weakening — MACD slipped below its signal line. Histogram contracting.

Bollinger Bands (20,2)

%B / Width31% · 23.2%

Mid-band — no directional band edge in play.

Volume · Buyer vs Seller

Up/Down vol1.8 · Accumulation
Rel volume0.68×

Accumulation — volume is concentrated on up days; buyers dominate. Recent volume is easing versus its baseline.

Support & Resistance

R · $207.00swing level
R · $231.8152-week high
Price · $201.27now
S · $186.64swing level
S · $178.88swing level
S · $157.63swing level

Fibonacci · Uptrend swing

23.6%$204.65
38.2%$187.85
50.0%$174.28
61.8%$160.70
78.6%$141.36

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for ILMN — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Weekly uptrendAbove 200-day MA50/200 bullishVolume accumulationRS 91 (leader)
Want this read in a legend's voice? Ask a Legend about ILMN
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 5 of 6 legends are Watching — building, not yet a confirmed buy.
Minervini
Watch
Minervini C

Trend-template read: 7/10 pass; wait for the soft misses to improve.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $201.27, MA150 $158.21, MA200 $153.15
1.2 150-day MA > 200-day MAMA150 $158.21 vs MA200 $153.15
Failing evidence
2. Quarterly EPS growth ≥ 25%From SEPA scan
2. ROE ≥ 17%From SEPA scan
7/10 checks
Method → Playbook → Ask →
O'Neil
Avoid
O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 91
N: Near 52-week high or RS line new high13.2% below high | RS line new high: False
Failing evidence
C: Quarterly EPS acceleration ≥ 25%Data unavailable
A: Annual earnings & revenue qualityRev -0.7%
3/8 checks
Method → Playbook → Ask →
Weinstein
Watch
Weinstein C

Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $201.27 vs MA200 $153.15
Failing evidence
Volume expansion above averageVolume ratio 0.68x
Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base
5/7 checks
Method → Playbook → Ask →
Livermore
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$201.27
Relative strengthRS 91
Failing evidence
Volume vs average0.68x
Pivotal point cleared on expanding volumeNot confirmed
4/6 checks
Method → Playbook → Ask →
Darvas
Watch
Darvas B

Box-theory read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$201.27
Relative strengthRS 91
Failing evidence
Volume vs average0.68x
Box top broken on heavy volumeNot confirmed
4/6 checks
Method → Playbook → Ask →
Wyckoff
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$201.27
Relative strengthRS 91
Failing evidence
Volume vs average0.68x
Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending
4/6 checks
Method → Playbook → Ask →
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Unlock Base & Breakout Tracking
RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising
181RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +4 A+
A: 19 D: 15 Net: +465 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 3/7 met
C 3/7 criteria
Separate score from the Minervini Trend Template (8/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
✗ EPS acceleration ≥25% QoQ —
✗ Revenue growth ≥20% YoY -1%
✗ Gross margin ≥30% —
✗ ROE ≥17% —
✓ RS rating ≥80 (leadership) 91
✓ Stage 2 uptrend (Weinstein) Stage 2
✓ Within 25% of 52W high -13.2%

Method Playbook

Trade it like Wyckoff EXACT LEVELS · PRO
Wyckoff B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use the Spring/test, Sign of Strength, creek, or Last Point of Support boundary identified by the active structure.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a completed test or Sign of Strength/Last Point of Support confirmation with improving demand versus supply.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start below the Spring/test low or structural support whose failure would invalidate the accumulation read.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Raise protection beneath successive Last Points of Support or meaningful higher lows during markup; never loosen it.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on a failed Sign of Strength, support loss, or clear supply-dominant reversal such as an upthrust failure.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Pattern Analysis

Trend Only
81 setup score
RS Score 91
Trend template 8/8 ✓
Why This Setup?
Trend Only · schematic

Gatekeeper 8/8 | Strong trend (8/8) | Top RS (91) | Accumulation (1.8× up/dn vol) | Stage 2

Ask a Legend ▾
The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

2/7 universals met
  • Risk is defined — not met No stop — undefined risk
  • Asymmetric reward — partly met No target set
  • Clear of earnings — partly met Report date unknown
  • Not chasing (in range) — partly met Pivot distance unknown
  • Volume confirms — partly met 0.7× average — light
  • A relative-strength leader — met RS rank 89
  • In a confirmed uptrend — met Stage 2 · Trend template 8/8
Why these seven? → The Universal Edge

Minervini Trend Template

8/8 ✓

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $201.27 vs SMA150 $158.21 / SMA200 $153.15
SMA 150 above SMA 200 SMA150 $158.21 vs SMA200 $153.15
SMA 200 trending up Slope +9.52 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $199.85
Price above SMA 50 $201.27 vs SMA50 $199.85
30%+ above 52-week low +128.7% from $88.00
Within 25% of 52-week high -13.2% from $231.81
RS score above 70 RS 91

Fundamentals

52W Range
79%
Mkt Cap SEC
30.4B
Rev YoY
-1%
EPS TTM
$5.45
P/E TTM
36.9x
Float
151M

Company

Company profile
Illumina, Inc.
ILMN · NASDAQ · Health Technology · Medical Specialties
Track all markets on TradingView

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
8/8
W. RS
100
W. Support
$115.31
W. Resist
$231.81
Weekly Structure

Scan History

20× streak
Sep 09: 50 (Wyckoff SOS)Sep 10: 50 (Wyckoff SOS)Sep 10: 52 (Wyckoff SOS)Sep 11: 81 (Trend Only)81
Sep 11
Trend Only ✓ Gate
81
Sep 10
Wyckoff SOS ✓ Gate
52 0.0%
Sep 10
Wyckoff SOS ✓ Gate
50 0.0%
Sep 09
Wyckoff SOS ✓ Gate
50 -1.8%

Get the full picture on ILMN

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial